Arix Bioscience

Arix Bioscience

Arix Bioscience

Suggest edits
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 10

Portfolio

Portfolio Tracker

Add info
Add round
19 May 2020
Amplyx Pharmaceuticals, Inc
Amplyx Pharmaceuticals, Inc
$53,000,000
Venture capital (Series C)
Adage Capital Management, BioMed Ventures, RiverVest, +7

Amplyx Pharmaceuticals Closes $53M Series C Extension

FinSMEs
+1
10 Aug 2018
Artios Pharma
Artios Pharma
£65,000,000
Venture capital (Series B)
Novartis Venture Fund, IP Group Plc, Arix Bioscience, +6

DNA Damage Response Company Artios Pharma Raises £65M in Series B

FinSMEs
10 Aug 2018
Artios Pharma
Artios Pharma
£65,000,000
Venture capital (Series B)
Novartis Venture Fund, Life Sciences Partners, IP Group Plc, +7
26 Sep 2017
Autolus Ltd.
Autolus Ltd.
$80,000,000
Venture capital (Series C)
Cormorant Asset Management, Nextech Invest, Arix Bioscience, +2
01 Aug 2017
Amplyx Pharmaceuticals, Inc
Amplyx Pharmaceuticals, Inc
$67,000,000
Venture capital (Series C)
3x5 Special Opportunity Fund, NEA, BioMed Ventures, +5

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

The San Diego Union-Tribune
+1
27 Jul 2017
PreciThera, Inc.
PreciThera, Inc.
$36,000,000
Venture capital (Series A)
Fonds de solidarité FTQ, Sanderling Ventures, Emerillon Capital, +2

Precision med startup PreciThera nets $36 mln in Series A round

PE HUB
+1
27 Jul 2017
PreciThera, Inc.
PreciThera, Inc.
$36,000,000
Venture capital (Series A)
Fonds de solidarité FTQ, Sanderling Ventures, CTI Life Sciences Fund, +2

PreciThera, Inc. Completes $36 Million Series A Financing

prnewswire
+1
29 Jun 2017
LogicBio Tx
LogicBio Tx
$45,000,000
Venture capital (Series B)
OrbiMed, Edmond de Rothschild Investment Partners, OrbiMed Israel Partners, +3

Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics

GlobeNewswire News Room
+1
21 Sep 2016
Artios Pharma
Artios Pharma
$33,200,000
Venture capital (Series A)
Imperial Innovations, SV Life Sciences, Arix Bioscience, +3

Artios Pharma Raises $33.2M in Series A Funding

FinSMEs